- Home
- EDIT vs MHI Comparison
EDIT vs MHI Comparison
Compare EDIT & MHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EDIT
- MHI
- Stock Information
- Founded
- EDIT 2013
- MHI 2003
- Country
- EDIT United States
- MHI United States
- Employees
- EDIT N/A
- MHI N/A
- Industry
- EDIT Biotechnology: Biological Products (No Diagnostic Substances)
- MHI Investment Managers
- Sector
- EDIT Health Care
- MHI Finance
- Exchange
- EDIT Nasdaq
- MHI Nasdaq
- Market Cap
- EDIT 179.1M
- MHI 208.1M
- IPO Year
- EDIT 2016
- MHI N/A
- Fundamental
- Price
- EDIT $2.75
- MHI $9.08
- Analyst Decision
- EDIT Buy
- MHI
- Analyst Count
- EDIT 12
- MHI 0
- Target Price
- EDIT $6.20
- MHI N/A
- AVG Volume (30 Days)
- EDIT 3.3M
- MHI 98.8K
- Earning Date
- EDIT 08-06-2025
- MHI 01-01-0001
- Dividend Yield
- EDIT N/A
- MHI 4.09%
- EPS Growth
- EDIT N/A
- MHI N/A
- EPS
- EDIT N/A
- MHI 0.04
- Revenue
- EDIT $35,837,000.00
- MHI N/A
- Revenue This Year
- EDIT N/A
- MHI N/A
- Revenue Next Year
- EDIT N/A
- MHI N/A
- P/E Ratio
- EDIT N/A
- MHI $219.25
- Revenue Growth
- EDIT N/A
- MHI N/A
- 52 Week Low
- EDIT $0.91
- MHI $6.93
- 52 Week High
- EDIT $6.05
- MHI $9.05
- Technical
- Relative Strength Index (RSI)
- EDIT 61.68
- MHI 47.81
- Support Level
- EDIT $2.48
- MHI $9.15
- Resistance Level
- EDIT $3.24
- MHI $9.21
- Average True Range (ATR)
- EDIT 0.26
- MHI 0.04
- MACD
- EDIT 0.02
- MHI -0.00
- Stochastic Oscillator
- EDIT 57.94
- MHI 20.00
About EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About MHI Pioneer Municipal High Income Fund Inc.
Pioneer Municipal High Income Trust is a diversified, closed-end management investment company. Its investment objective is to seek a high level of current income exempt from regular federal income tax and capital appreciation. The trust invests in various sectors such as health, education, tobacco, facilities, transportation, utilities, airport, water, and other sectors.